Donald Stanski

Dr. Stanski has served in senior executive roles as Vice President and Global Head, Quantitative Clinical Pharmacology at AstraZeneca Pharmaceuticals and Vice President and Global Head, Modeling and Simulation at Novartis Pharma AG. He was formerly a Scientific Advisor to the FDA Deputy Commissioner, where he introduced new quantitative methods into the regulatory review process for drugs and medical devices. In addition to his industry career, he served as Professor and Chairman of the Department of Anesthesiology at Stanford University's School of Medicine. He currently serves as Professor Emeritus at Stanford.